Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| Affymax and Takeda to Present Additional Peginesatide Phase 3 Data in Dialysis ... - PharmiWeb.com (press release) |
 |
 |
|
PharmiWeb.com (press release) Peginesatide is an investigational agent in development by Affymax and Takeda for the treatment of anemia in chronic renal failure patients on dialysis. The companies and investigators will present three posters highlighting Phase 3 data on |
